Grants & Projects per year
Personal profile
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
GO44900: A Phase Ib Study Evaluating Safety Efficacy Pharmacokinetics & Pharmacodynamics of Glofitamab in Comination with Gemcitabine plus Oxaliplatin in Patients from Racial-Ethnic Minorities with Relapsed or Refractory Diffuse Cell Lympho
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
05/1/26 → 01/28/27
Project: Research
-
Ntrust-2: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy in Subjects with Immune-Mediated Diseases
Schuster, M. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI) & Liu, S. (CoPI)
05/5/25 → 02/3/27
Project: Research
-
GO43878: A Phase III, Open-label, Multicenter, Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
06/26/26 → 08/29/26
Project: Research
-
Ntrust-1: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with Autoimmune Disease
Yao, Q. P. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI), Liu, S. (CoPI) & Schuster, M. (CoPI)
05/16/25 → 08/19/26
Project: Research
-
Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6
Andorsky, D., Lopez, A. T., Vaidya, R., Madueno, F. V., Ibrahimi, S., Naik, S., Gandhi, M., Haydu, J. E., Lash, B., Fesler, M., Hrom, J., Lee, E. H., Sundaram, S., Conte, K., Osei-Bonsu, K., Doerr, T., Bai, Y., Dixit, N., Eskelund, C. W. & Boardman, A. P. & 3 others, , May 2026, In: Clinical Lymphoma, Myeloma and Leukemia. 26, 5, p. 317-327.e10Research output: Contribution to journal › Article › peer-review
Open Access -
CD4+ mucosal-associated invariant T cells express highly diverse T cell receptors
Kaur, R., Xie, D., Pradhan, A., Mehanna, N., Li, K., Aubé, J., Rosati, B., Carlson, D., Lee, C. Y. & Vorkas, C. K., Dec 2025, In: Journal of Immunology. 214, 12, p. 3260-3272 13 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Malignancy-associated haemophagocytic lymphohistiocytosis
Setiadi, A., Zoref-Lorenz, A., Lee, C. Y., Jordan, M. B. & Chen, L. Y. C., Mar 2022, In: The Lancet Haematology. 9, 3, p. e217-e227Research output: Contribution to journal › Review article › peer-review
110 Scopus citations -
Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies
Lee, C. Y., Shah, M. K., Hoyos, D., Solovyov, A., Douglas, M., Taur, Y., Maslak, P., Babady, N. E., Greenbaum, B., Kamboj, M. & Vardhana, S. A., 2022, In: Cancer Discovery. 12, 1, p. 62-73 12 p.Research output: Contribution to journal › Article › peer-review
Open Access127 Scopus citations -
Rotational thromboelastometry in patients with acute respiratory distress syndrome owing to coronavirus disease 2019: Is there a viscoelastic fingerprint and a role for predicting thrombosis?
Vasovic, L. V., Littlejohn, J., Alqunaibit, D., Dillard, A., Qiu, Y., Rand, S., Bronstein, M., Gibson, C. J., Kelly, A. G., Lee, C., Minneman, J. A., Narayan, M., Shou, J., Smith, K. E., Villegas, C. V., Winchell, R. J., Cushing, M. M. & Barie, P. S., Apr 2022, In: Surgery (United States). 171, 4, p. 1092-1099 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations